Tirzepatide use is linked to lower risks of incident and progressive diabetic retinopathy compared with lifestyle intervention alone.

This research initiative highlights the importance of ethical and explainable artificial intelligence in workforce ...

The popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell ...

In research published in the journal Gut, investigators from the University of Alabama at Birmingham report that restoring tryptophan metabolism in the gut microbiome can prevent or reverse diabetic ...

Diabetic retinopathy (DR), a leading cause of vision impairment among working-age adults, affects approximately 146 million individuals globally, with projections estimating an increase to 180 million ...

Sticking to your medication plan, managing your blood sugar, and taking care of your mental health can all be important components of self-care for diabetic retinopathy. Self‑care can’t cure diabetic ...

Background/Aims Diabetic retinopathy (DR) is a major ocular complication of diabetes mellitus. While artificial intelligence (AI)-based DR screening tools have gained widespread adoption, most ...

Ensemble deep-learning system with xAI (Grad-CAM) for automated diabetic retinopathy detection and staging using retinal fundus images.

Please provide your email address to receive an email when new articles are posted on . Social deprivation was independently associated with increased risk for diabetic retinopathy. Disparities in ...

Diabetic retinopathy is a complication of diabetes caused by uncontrolled blood sugar levels damaging the blood vessels and eye tissue located at the retina. The condition occurs in patients with both ...

Diabetic retinopathy (DR), the leading cause of blindness globally, is currently detected via the ETDRS diabetic retinopathy severity scale (DRSS). While effective, there are now new ways to screen, ...